Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
HCPCS Level II Code

HCPCS code Q4150 Allowrap ds or dry


Code Definition

Q4150 is the HCPCS Level II code for allowrap ds or dry, per square centimeter (add-on, list separately in addition to primary procedure).

Medicare covers Q4150 for chronic non-healing lower extremity wounds that meet the medical necessity criteria in the applicable Local Coverage Determination.

Level
Level II
Category
Q — Temporary codes
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

HCPCS Code Q4150 describes Allowrap DS or dry, billed per square centimeter, as a temporary Q-series skin substitute code assigned by CMS.

Medicare covers Q4150 for chronic non-healing wounds when the medical necessity criteria and the documentation requirements are met.

Units come from the measured wound surface area in sq cm, and unit errors are the most common reason a claim is denied.

Q4100, the non-specific skin substitute code, was deleted effective December 31, 2025, so it is not billable in 2026.

Pabau, a practice management platform, helps wound care practices record wound measurements and track Q4150 claims through adjudication.

HCPCS Code Q4150: Definition and code details

Short description: Allowrap DS or dry, per sq cm. Long description: Allowrap DS or dry, per square centimeter.

Q4150 is a temporary Level II code that identifies a bioengineered skin substitute graft applied during a wound care procedure. CMS assigns and maintains these Q-series codes through its HCPCS Level II process. The code sits in the Q4100 series, which covers skin substitute products billed per square centimeter applied.

Field Details
HCPCS Code Q4150
Short Description Allowrap DS or dry, per sq cm
Long Description Allowrap DS or dry, per square centimeter
Code Category Temporary HCPCS Level II (Q-series) – Drugs, Biologicals, and Skin Substitutes
Code Series Q4100 series (skin substitute graft products)
Unit of Service Per square centimeter of product applied
Status (2026) Active

Coders often ask which formulation Q4150 covers. It covers both the DS (dual-sided) and the dry forms of Allowrap. Confirm which one was applied by checking the product invoice and the operative note before submitting.

What is Allowrap DS?

Allowrap DS is a bioengineered skin substitute used on chronic, non-healing wounds, particularly lower extremity ulcers. It works as a scaffold that supports tissue regeneration at the wound site. The product is applied directly over the wound bed and secured in place, where it integrates with the surrounding tissue over the following weeks.

Clinically, Allowrap DS is indicated for diabetic foot ulcers, venous leg ulcers, and pressure injuries that have not responded to standard wound care. Medicare coverage requires that the wound meets chronicity criteria.

Those criteria are usually defined as a wound present for four or more weeks with no improvement under conventional treatment. Document the chronicity and the prior treatment history before billing HCPCS Code Q4150.

  • Diabetic foot ulcers that have not healed after four or more weeks of standard care
  • Venous leg ulcers with documented compression therapy failure
  • Pressure injuries (Stage 3 or 4) on the lower extremity
  • Post-surgical or traumatic wounds meeting chronicity criteria under the applicable LCD

Medicare fee schedule and reimbursement rates for 2026

Medicare reimburses HCPCS Code Q4150 at facility and non-facility rates that are updated annually. Both are adjusted geographically using the Geographic Practice Cost Index (GPCI).

Verify current rates against the CMS Physician Fee Schedule lookup tool before submitting claims, since rates vary by Medicare Administrative Contractor (MAC) jurisdiction.

Rate Type Description Notes
Facility rate Medicare payment when the service is provided in a facility (hospital outpatient, ASC) Lower than the non-facility rate; practice overhead is covered separately
Non-facility rate Medicare payment when the service is provided in a physician office or wound care practice Higher rate; covers practice overhead costs
Geographic adjustment GPCI modifier applied by MAC jurisdiction Rates vary between high-cost and rural areas
Billing unit Per square centimeter applied Units must match the documented wound surface area, rounded to the nearest whole sq cm

Because payment runs per square centimeter, accurate wound measurement at the time of service is critical. A unit count that does not match the measured wound is a frequent trigger for post-payment audits. Standardize the measurement protocol and record it in the clinical note on the same date of service.

Pro Tip

Verify the 2026 Q4150 rate for your own MAC jurisdiction using the CMS Physician Fee Schedule lookup before each plan year starts. Geographic adjustment moves the effective rate between high-cost and rural jurisdictions. A national average figure in your revenue projections will produce consistent shortfalls.

Medicare and commercial payer coverage

Medicare covers HCPCS Code Q4150 for chronic non-healing wounds of the lower extremity under the applicable Local Coverage Determination.

Coverage is not automatic, and every claim is subject to medical necessity review. Sound medical billing compliance starts with confirming that the patient meets the payer’s clinical criteria before the product is applied.

Medical necessity and coverage criteria

CMS and most commercial payers require the following criteria to be documented before a Q4150 claim will be considered for payment.

  • Wound present for four or more weeks with no measurable improvement despite standard care
  • Standard wound care attempted and documented (dressings, debridement, offloading as applicable)
  • Underlying conditions managed (e.g., blood glucose controlled for diabetic ulcer cases)
  • Wound dimensions measured and recorded at the time of each application
  • Treatment plan on file with stated wound care goals and review intervals
  • Product invoice or acquisition record available to support the claim

Commercial payer coverage for skin substitutes varies widely. Blue Cross Blue Shield policies, for example, differ by state affiliate and may require prior authorization for Q4150 applications. Verify prior authorization requirements with each payer before the first application, not after a denial arrives.

Practices billing several payers should keep a payer-specific coverage matrix for the Q4100 series. LCD policies list both the covered ICD-10 codes and the exclusions that trigger an automatic denial. It pays to know which denial codes a skin substitute claim tends to attract.

ICD-10 codes that support medical necessity

Every Q4150 claim needs a supporting ICD-10 diagnosis code that establishes medical necessity. The codes below are among those commonly accepted under Medicare LCDs for skin substitute applications on lower extremity wounds. This list is representative, not exhaustive. Always verify against the LCD and the payer policy that apply in your MAC jurisdiction.

ICD-10 Code Description Wound Type
E11.621 Type 2 diabetes mellitus with foot ulcer Diabetic foot ulcer
E11.622 Type 2 diabetes mellitus with other skin ulcer Diabetic skin ulcer (non-foot)
I83.009 Varicose veins of unspecified lower extremity with ulcer of unspecified site Venous leg ulcer
L97.109 Non-pressure chronic ulcer of unspecified thigh with unspecified severity Chronic lower extremity ulcer
L97.509 Non-pressure chronic ulcer of other part of unspecified foot with unspecified severity Chronic foot ulcer
L89.623 Pressure ulcer of left heel, stage 3 Pressure injury (heel)
L89.513 Pressure ulcer of right ankle, stage 3 Pressure injury (ankle)

Code specificity matters. Medicare edits flag claims that use a non-specific laterality or severity code when a more specific one exists.

For diabetic ulcer cases, use the code that identifies the anatomical site and, where applicable, the severity. For venous ulcers, document the involved extremity and the ulcer location so the most specific code can be assigned.

Q4150 billing and coding guidelines

Accurate Q4150 billing depends on the unit calculation, the place of service, the modifiers, and the bill type. An error in any one of them can produce a denial or a post-payment recovery.

Billing Element Requirement
Unit calculation Bill one unit per sq cm applied. Measure wound length x width and round to the nearest whole sq cm.
Place of service POS 11 (Office), POS 19 (Off-Campus Outpatient Hospital), or POS 22 (On-Campus Outpatient Hospital) as applicable. The POS code determines the facility or non-facility rate.
Companion CPT codes Bill the skin substitute application CPT codes (15271-15278) alongside Q4150 for the same date of service. The CPT code identifies the procedure. Q4150 identifies the product.
Modifiers Apply RT or LT for laterality. Some payers also require the KX modifier to indicate that the medical necessity criteria are met.
Bill type (institutional) 13X for hospital outpatient; 85X for critical access hospital outpatient
Revenue codes 0278 (medical/surgical supplies) is typically used on institutional claims

Documentation requirements for each application

Insufficient documentation is the leading reason Q4150 claims fail on audit. The clinical record for each date of service needs all of the following elements.

  • Wound measurements: Length, width, and depth recorded in centimeters, dated and signed
  • Wound description: Wound bed characteristics, exudate level, periwound tissue status
  • Chronicity evidence: Date of wound onset and a record of prior treatment over the previous four-plus weeks
  • Treatment plan: Signed plan specifying the skin substitute product, the application frequency, and measurable healing goals
  • Product invoice: Itemized invoice showing the Allowrap DS product, the lot number, and a quantity matching the units billed
  • Progress notes: Dated clinical notes for each application visit, referencing wound response and any change to the plan
  • Prior authorization confirmation: Written confirmation or reference number from the payer where it is required

Those elements are gathered in a fixed order, because each one is a precondition for the next. A payer’s reviewer walks the same sequence in reverse when a Q4150 claim is audited.

Five ordered checks before a Q4150 claim.
Measurement sits fourth, which is why so many Q4150 denials trace back to a visit that was clinically sound. Source: the Medicare LCD coverage criteria and HCPCS billing rules set out above.

A digital documentation workflow for wound care visits captures these elements consistently. That lowers the risk of a claim being paid on submission and then recovered on retrospective audit.

Pabau digital forms used for wound care documentation
Pabau’s digital forms hold the wound measurements, chronicity notes and invoice details that every Q4150 claim has to prove.

The Q4100 series covers the range of skin substitute graft products billed to Medicare and commercial payers. When selecting a code, confirm the exact product applied against the HCPCS code description.

Using the wrong Q-code for the product on the invoice is an automatic denial trigger and a False Claims Act risk. The AAPC HCPCS code lookup carries searchable Q4100-series listings for cross-reference.

HCPCS Code Product Name Description
Q4100 Skin substitute, not otherwise specified Deleted by CMS effective 12/31/2025. Not billable for 2026 dates of service.
Q4101 Apligraf Bioengineered bilayer living cellular construct, per sq cm
Q4102 Oasis wound matrix Porcine small intestine submucosa extracellular matrix, per sq cm
Q4107 Graftjacket Human dermis allograft, per sq cm
Q4116 AlloDerm Human dermis acellular allograft, per sq cm
Q4150 Allowrap DS or dry Bioengineered skin substitute, per sq cm (this code)
Q4180 Revita Placental membrane allograft, per sq cm

Q4100 used to be the non-specific fallback for a skin substitute with no product-specific code. CMS deleted it effective December 31, 2025, so a 2026 claim carrying Q4100 rejects as an invalid code.

Map each product SKU or lot number to its own HCPCS code in a reference table. Review that table whenever CMS publishes a quarterly HCPCS update.

How Pabau supports wound care billing

Wound care practices billing HCPCS Code Q4150 work through a documentation-heavy process. One missing measurement, a miscalculated unit count, or an unconfirmed prior authorization can stall payment for weeks.

Pabau is practice management software, and its wound care claims software gives billing teams a structured workflow for that record. Staff capture wound measurements at the point of care, and the system flags missing documentation before the claim is submitted. Each Q4150 submission is then tracked through the payer’s adjudication process.

For practices managing several payers with different Q4150 policies, Pabau’s reporting identifies denial patterns by payer and by code. Billing teams can then fix the systemic cause instead of chasing individual rejections. Configurable treatment forms keep the measurement fields and the product invoice inside the patient record.

Pabau claims dashboard tracking submitted claims and billing status
Pabau’s claims view shows where each Q4150 submission sits, so nobody has to call the payer to find out.

Streamline your wound care billing workflow

Pabau helps wound care practices capture accurate wound measurements, manage documentation for skin substitute claims, and catch billing errors before claims are submitted.

Pabau wound care billing workflow

Conclusion

HCPCS Code Q4150 is a simple code sitting inside a demanding billing environment. The description is fixed: Allowrap DS or dry, per square centimeter, active for 2026. The work that decides payment happens before the claim is built.

All five checks above are documentation tasks rather than billing tasks. Practices that move them into the clinical visit, instead of into the appeals process, carry much cleaner accounts receivable on skin substitute claims. The trade-off is a slightly longer visit in exchange for a shorter collection cycle.

Pabau’s wound care documentation tools capture each required element at the point of care. Book a demo to see how that works for skin substitute billing and Q4150 claims.

Continue your research

Continue your research

Want the full path from charge capture to collections? Revenue cycle management covers each stage a skin substitute claim passes through.

Seeing repeated denials on skin substitute claims? Denial management in healthcare explains how to analyze denial patterns and build a systematic appeals process.

Want more Q4150 claims paid on first submission? What a clean claim is sets out the fields a payer checks before it adjudicates.

Building the charge sheet for a wound care visit? How a superbill works shows which fields the form has to carry.

New to the billing side of wound care? What is medical billing walks through the process from encounter to payment.

Frequently asked questions

What is HCPCS Code Q4150?

HCPCS Code Q4150 is a temporary Level II HCPCS code that describes Allowrap DS or dry, billed per square centimeter. CMS assigns it to identify the Allowrap bioengineered skin substitute when it is applied to chronic, non-healing wounds. The code is part of the Q4100 series, which covers skin substitute graft products billed to Medicare and commercial payers.

What is Allowrap DS used for in wound care billing?

Allowrap DS is a bioengineered skin substitute applied to chronic lower extremity wounds. Those include diabetic foot ulcers, venous leg ulcers, and pressure injuries that have not responded to conventional wound care. In billing terms, Q4150 is reported alongside the skin substitute application CPT codes (15271-15278). The claim then identifies both the procedure performed and the product used.

What are Q codes in medical billing?

Q codes are temporary Level II HCPCS codes assigned by CMS. They describe drugs, biologicals, and specific medical products, including skin substitutes, that have no permanent code assignment yet. CMS maintains them rather than the AMA, and updates them through the year as new products receive HCPCS assignments. HCPCS Code Q4150 is one such Q-series code, covering the Allowrap DS skin substitute.

How is Q4150 reimbursed by Medicare?

Medicare reimburses Q4150 under the Physician Fee Schedule, at the facility or non-facility rate depending on the place of service. The rate is then adjusted by the Geographic Practice Cost Index for the MAC jurisdiction. Payment runs per square centimeter applied, so the unit count on the claim must match the wound measurement documented that day. Confirm actual 2026 rates through the CMS Physician Fee Schedule lookup tool.

What documentation is required to bill Q4150?

Required documentation includes wound measurements in centimeters, evidence of chronicity over four or more weeks of prior treatment, and a signed treatment plan. You also need an itemized product invoice matching the billed units. Add dated progress notes for each application visit, plus prior authorization confirmation where the payer requires it. A single missing element is enough to support a denial or a post-payment audit recovery.

Is Q4150 covered by commercial insurance payers?

Coverage varies by payer and by plan. Many commercial payers follow the Medicare LCD criteria for skin substitutes. Others require separate prior authorization, or cap the number of applications covered per wound. Verify prior authorization requirements and coverage criteria with each payer before applying Allowrap DS, because retroactive denials on high-cost skin substitutes are difficult to reverse.

×